West Pharmaceutical-West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand

West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’s third-quarter 2025 earnings surpassed analyst estimates.West Pharmaceutical reported adjusted earnings of $1.96 per share, beating the consensus of$ 1.68.Net sales of $804.6 million increased 7.7% year over year, with organic growth was 5.0%, beating the consensus of$ 787.93 million.“Our strength was broad-based, across both our Proprietary Products and Contract M ...